BioAmber Inc fka BIOAQ

[Koan]

Let's state this another way:

PwC did not need anyone to come in and purchase any of BioAmber's assets or business for less than scrap value. As the court appointed monitor, PwC was managing all of the critical financial and operational affairs of BioAmber.

Therefore, in the absence of a bid commensurate with scrap value, PwC themselves could have sold off BioAmber's assets for scrap value, which exceeds 4.3 million.

This fact alone has yet to be answered, and likely for good reason. It does not make sense and would require extensive distortion of basic reasoning and elementary level business judgement.